To determine whether the anti-tumor activity of Tan in ESCC is due to the reduction of GPNMB, a GPNMB cDNA plasmid was introduced before Tan treatment and assayed for cell migration and invasiveness. The gene discussed is GPNMB; the disease is esophageal squamous cell carcinoma.